Selective Serotonin Reuptake Inhibitors for Treating Neurocognitive and Neuropsychiatric Disorders Following Traumatic Brain Injury: An Evaluation of Current Evidence

The prevalence of neuropsychiatric disorders following traumatic brain injury (TBI) is 20%–50%, and disorders of mood and cognition may remain even after recovery of neurologic function is achieved. Selective serotonin reuptake inhibitors (SSRI) block the reuptake of serotonin in presynaptic cells t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Brain Sci
Main Authors: Yue, John K., Burke, John F., Upadhyayula, Pavan S., Winkler, Ethan A., Deng, Hansen, Robinson, Caitlin K., Pirracchio, Romain, Suen, Catherine G., Sharma, Sourabh, Ferguson, Adam R., Ngwenya, Laura B., Stein, Murray B., Manley, Geoffrey T., Tarapore, Phiroz E.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2017
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5575613/
https://ncbi.nlm.nih.gov/pubmed/28757598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/brainsci7080093
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados